Insider · CIK 0001762176
Anderson Karen M.
officer
Files at CNTA (Centessa Pharmaceuticals plc). First filing Dec 17, 2024, latest Feb 10, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 3
$0 bought, $982k sold
Signals
This insider’s open-market buys and sells, scored.
| Score | Side | Company | Value | Shares | Holdings change | Price context | Filed |
|---|---|---|---|---|---|---|---|
| 9Weak | sell10b5-1 | CNTA Centessa Pharmaceuticals plc | $589k | 30,955 | -36% | - | |
| 10Weak | sell10b5-1 | CNTA Centessa Pharmaceuticals plc | $109k | 6,471 | -11% | - | |
| 14Weak | sell 510b5-1 | CNTA Centessa Pharmaceuticals plc | $284k | 16,500 | -21% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 7, 2025 | CNTA Centessa Pharmaceuticals plc | MOption exercise Ordinary Shares10b5-1 | +30,526 | $4.01 | $122k | 84,848 | Feb 10, 2025 |
| Feb 7, 2025 | CNTA Centessa Pharmaceuticals plc | SOpen-market sale Ordinary Shares10b5-1 | -30,526 | $19.03 | $581k | 54,322 | Feb 10, 2025 |
| Feb 10, 2025 | CNTA Centessa Pharmaceuticals plc | MOption exercise Ordinary Shares10b5-1 | +429 | $4.01 | $1,720 | 54,751 | Feb 10, 2025 |
| Feb 10, 2025 | CNTA Centessa Pharmaceuticals plc | SOpen-market sale Ordinary Shares10b5-1 | -429 | $18.99 | $8,147 | 54,322 | Feb 10, 2025 |
| Feb 7, 2025 | CNTA Centessa Pharmaceuticals plc | MOption exercise Share Option (right to buy)derivative10b5-1 | -30,526 | $0.00 | $0 | 244,464 | Feb 10, 2025 |
| Feb 10, 2025 | CNTA Centessa Pharmaceuticals plc | MOption exercise Share Option (right to buy)derivative10b5-1 | -429 | $0.00 | $0 | 244,035 | Feb 10, 2025 |
| Feb 1, 2025 | CNTA Centessa Pharmaceuticals plc | FTax withholding Ordinary Shares10b5-1 | -10,732 | $16.92 | $182k | 60,793 | Feb 4, 2025 |
| Feb 3, 2025 | CNTA Centessa Pharmaceuticals plc | SOpen-market sale Ordinary Shares10b5-1 | -6,471 | $16.86 | $109k | 54,322 | Feb 4, 2025 |
| Feb 3, 2025 | CNTA Centessa Pharmaceuticals plc | AGrant or award Share Option (right to buy)derivative10b5-1 | +120,000 | $0.00 | $0 | 120,000 | Feb 4, 2025 |
| Dec 13, 2024 | CNTA Centessa Pharmaceuticals plc | MOption exercise Ordinary Shares10b5-1 | +5,876 | $3.85 | $23k | 77,401 | Dec 17, 2024 |
| Dec 13, 2024 | CNTA Centessa Pharmaceuticals plc | SOpen-market sale Ordinary Shares10b5-1 | -5,876 | $17.01 | $100k | 71,525 | Dec 17, 2024 |
| Dec 17, 2024 | CNTA Centessa Pharmaceuticals plc | MOption exercise Ordinary Shares10b5-1 | +10,624 | $3.85 | $41k | 82,149 | Dec 17, 2024 |
| Dec 17, 2024 | CNTA Centessa Pharmaceuticals plc | SOpen-market sale Ordinary Shares10b5-1 | -10,624 | $17.32 | $184k | 71,525 | Dec 17, 2024 |
| Dec 13, 2024 | CNTA Centessa Pharmaceuticals plc | MOption exercise Share Option (right to buy)derivative10b5-1 | -5,876 | $0.00 | $0 | 54,134 | Dec 17, 2024 |
| Dec 17, 2024 | CNTA Centessa Pharmaceuticals plc | MOption exercise Share Option (right to buy)derivative10b5-1 | -10,624 | $0.00 | $0 | 43,510 | Dec 17, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.